KURA Brian T Powl sells $99K worth of shares
Nov 15, 2025, 5:36 AM
0.00%
What does KURA do
Kura Oncology, headquartered in San Diego, focuses on developing precision medicines for cancer treatment, including small molecule candidates Ziftomenib, Tipifarnib, and KO-2806. The company went public in November 2015 and employs 142 staff.
Brian T Powl sold 8,887 shares of KURA on 14 November at $11.18 per share, worth a total of $99K. They now own 139,689 KURA shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.